Vergoeding 2016-2020 voor ATC-subgroep N05AX : Overige antipsychotica
- Raming voor de totale Zvw-populatie
| 2016 | 2017 | 2018 | 2019 | 2020 | |
|---|---|---|---|---|---|
| N05AX08 Risperidon (Risperdal ®) | 5.799.100 | 5.064.500 | 4.643.700 | 4.587.300 | 4.264.800 |
| N05AX12 Aripiprazol (Abilify maintena ®) | 16.117.300 | 10.797.200 | 10.436.100 | 11.176.500 | 11.466.100 |
| N05AX13 Paliperidon (Xeplion ®) | 8.632.000 | 9.813.800 | 10.571.100 | 11.733.600 | 12.230.300 |
| N05AX15 Cariprazine (Reagila ®) | . | . | 4.180 | 150.910 | 334.130 |
| N05AX16 Brexpiprazol (Rxulti ®) | . | . | . | 38.014 | 156.890 |
| Totaal | 30.548.400 | 25.675.500 | 25.655.080 | 27.686.324 | 28.452.220 |